Campanati Anna

60PUBLICATIONS
129CO-AUTHORS
Traditional Chinese medicine and treatmentsPredictive and prognostic markersMajor global burdens of diseaseToxicology (incl. clinical toxicology)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|Mar 23, 2026
Advances in pharmacological treatment and management of hyperhidrosis.

A Rossi, H Gioacchini, A Marani

|Mar 07, 2026
TROP-2 Is Not a Therapeutic Target in Melanoma: a Morphological Study.

Sonia Fantone, Daniela Marzioni, Elisa Molinelli

|Feb 16, 2026
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis).

Emanuele Trovato, Alessandra Cartocci, Francesca Gaiani

|Sep 04, 2025
Strategies for Optimal Use of Biological Therapies in Managing Psoriasis: Focus on Secukinumab.

Anna Balato, Martina Burlando, Anna Campanati

|May 29, 2025
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study.

Riccardo Balestri, Giulia Odorici, Michela Magnano

|May 13, 2025
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis).

Helena Gioacchini, Agnese Rossi, Maria Esposito

Pageof 10

Frequent Collaborators

22 joint publications

Federico Diotallevi

21 joint publications

Radi Giulia

15 joint publications

Annamaria Offidani

12 joint publications

Elisa Molinelli